Abigail Blunt Buys 6,859 Shares of AMBP

Abigail Blunt recently acquired 6,859 shares of AMBP on June 15, 2026. This insider purchase was not part of a pre-arranged trading plan, as indicated by the transaction code 'A'. The details around the purchase price and total value were not disclosed.

Other Institutional Activity in AMBP

Canyon Capital Advisors LLC reduced its holdings in AMBP by 919,516 shares, leaving it with 11,523,328 shares valued at about $46.67 million. BlackRock, Inc. also cut its position by 279,732 shares, ending with 7,734,868 shares worth approximately $31.33 million. Conversely, Goldman Sachs Group Inc. increased its stake by 497,116 shares, bringing its total to 7,288,484 shares valued at $29.52 million. Arini Capital Management Ltd and Platinum Equity, LLC maintained their holdings without any changes.

AMBP Stock Snapshot

Shares of AMBP traded near $4.30. The stock's recent movements reflect a 52-week trading range that has yet to be fully detailed in this report. Despite the current market conditions, AMBP continues to attract attention from both institutional and individual investors.

Analysts Set New Price Targets

On April 24, 2026, Citigroup maintained a 'buy' rating on AMBP with a price target of $5.00. Wells Fargo consistently maintained a 'hold' rating with varying targets, most recently setting it at $4.00 on March 20, 2026. UBS also kept a 'hold' rating, with their most recent target at $4.25 on January 12, 2026. These ratings suggest a mixed outlook on the stock's future performance.

Bottom Line

Abigail Blunt's recent purchase of AMBP shares is a notable insider activity, reflecting potential confidence in the company's prospects. Institutional investors have shown varied actions, with some reducing and others increasing their stakes in AMBP. Analyst opinions remain mixed, with recent recommendations ranging from 'hold' to 'buy'. As always, these insights are based on past transactions and should be interpreted with caution.